Narrow search
Showing 1 - 10 of 463,761
Cover Image
Public debate : the US food and drug administration and new drug approvals ; a safety vs. innovation paradox?
Hemphill, Thomas A. - In: Innovation: organization & management : IOM 15 (2013) 3, pp. 364-367
Persistent link: https://www.econbiz.de/10010226637
Cover Image
Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industry
Giaccotto, Carmelo - In: The journal of law & economics 48 (2005) April, pp. 195 - 214
Persistent link: https://www.econbiz.de/10002895264
Cover Image
The economic consequences of US FDA new drug approvals : evidence from Taiwan pharmaceutical and biotech companies
Chen, Yong-Jie; Feng, Zhi-Yuan; Li, Yueh-Ping; Huang, … - In: Innovation: organization & management : IOM 23 (2021) 3, pp. 354-374
Persistent link: https://www.econbiz.de/10012649635
Cover Image
The future of pharmaceuticals : the changing environment for new drugs
Bezold, Clement - 1981
Persistent link: https://www.econbiz.de/10013490222
Cover Image
Research expenditures and the discovery of new drugs
Jensen, Elizabeth J. - In: The journal of industrial economics 36 (1987) 1, pp. 83-95
Persistent link: https://www.econbiz.de/10001044708
Cover Image
FDA approval announcements : attention-grabbing or event-day misspecification?
Hamill, Philip; Hutchinson, Mark; Quang Minh Nhi Nguyen; … - In: Economics letters 170 (2018), pp. 171-174
Persistent link: https://www.econbiz.de/10012019644
Cover Image
Product safety spillovers and market viability for biologic drugs
Romley, John; Shih, Tiffany - In: International journal of health economics and management 17 (2017) 2, pp. 135-158
Persistent link: https://www.econbiz.de/10011814117
Cover Image
Regulation and drug development
Wardell, William M.; Lasagna, Louis - 1975
Persistent link: https://www.econbiz.de/10000584247
Cover Image
Federal regulation of the drug industry
Kleinfeld, Vincent A. (contributor) - 1974
Persistent link: https://www.econbiz.de/10000328804